CONDUIT PHARMACEUTICALS INC. Annual Income Tax Expense (Benefit) in USD for 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Conduit Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for 2022.
  • Conduit Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $213K, a 616% increase year-over-year.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $375K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.